Toronto (ots/PRNewswire) - Bank of Montreal ("BMO") (TSX: BMO)(NYSE: BMO) today announced that the Toronto Stock Exchange ("TSX") has accepted BMO's amended notice of intention to make a Normal Course Issuer Bid. The notice has been amended to, among other things, permit the repurchase by BMO of its common shares ...
issuer: RHI AG Wienerbergstrasse 9 A-1100 Wien phone: +43 (0)50213-6676 FAX: +43 (0)50213-6130 mail: rhi@rhi-ag.com WWW: http://www.rhi-ag.com ISIN: AT0000676903 indexes: ATX stockmarkets: Wien language: English ...
Darmstadt, Germany (ots/PRNewswire) - - Efficacy and safety data support positive benefit/risk assessment from CHMP - Cladribine Tablets is the first and only investigational medicinal product to have shown a sustained 4 years of disease control with a maximum of 20 days of oral treatment over 2 years in clinical ...
Geneva (ots/PRNewswire) - Leading specialists at ICPIC congress come together to discuss the issue of SSIs and recent guidelines regarding the use of triclosan-coated sutures in all types of surgery[6] Ethicon* part of the Johnson & Johnson Medical Devices Companies** has joined leading wound closure specialists to discuss recommendations to ease the burden of surgical site infections (SSIs) on patients and costs to ...
EQS Group-News: Zur Rose Group AG / Key word(s): IPO Zur Rose Group AG launches IPO on SIX Swiss Exchange and sets price range 22.06.2017 / 07:00 585131 22.06.2017 ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - VEYVONDI is the first and only recombinant von Willebrand factor treatment for adults with von Willebrand disease, the most common inherited bleeding disorder[1],[2],[3] Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare ...
Frankfurt am Main (ots) - - 1947: US Secretary of State George C. Marshall launches the "European Recovery Program" (ERP) - 1948: KfW is founded to channel the ERP funds - Promotional business volume of KfW since its foundation totals over EUR 1.5 trillion 2017 marks the seventieth anniversary of the announcement of the Marshall Plan, one of KfW's most significant historical foundations. On behalf of the German Federal ...
Craigavon, N.I., UK, Lausanne, Switzerland (ots) - Almac Discovery (www.almacgroup.com/discovery), a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Debiopharm International SA (Debiopharm - www.debiopharm.com), a Switzerland based specialty ...
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Offer Kaufangebot für alle Aktionäre der Linde Holding Biel/Bienne AG: Swiss Medical Network SA erhöht ihr Angebot in bar auf CHF 3'100 infolge der Erhöhung des Gegenangebots von Hirslanden 20-Jun-2017 / 16:25 CET/CEST Release of an ad hoc announcement pursuant ...
Sunnyvale, California (ots/PRNewswire) - The French Cancer Institute is Building its Re-irradiation and Adaptive Radiotherapy Program Using the Latest Technology Developed by Accuray Accuray Incorporated (NASDAQ: ARAY) announced today that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) is providing advanced radiation treatments to cancer patients ...
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT0000603709 indexes: WBI stockmarkets: Berlin, Frankfurt, Stuttgart, Wien language: English ...
Hørsholm, Denmark (ots/PRNewswire) - - Allergic rhinitis has a major impact on children's quality of life - Children with allergic rhinitis have an increased risk of developing asthma - Early treatment may prevent asthma symptoms In a symposium sponsored by ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF), leading ...
Luxembourg, and Ness Ziona, Israel (ots) - - Cross reference: Picture is available at http://www.presseportal.de/pm/127019/3664051 - The European Investment Bank (EIB) and BiondVax Pharmaceuticals Ltd., developer of the Universal Flu Vaccine candidate M-001, announced that they have entered into a EUR20 million loan ...
EQS Group-News: Zur Rose Group AG / Key word(s): AGM/EGM Extraordinary General Meeting of Zur Rose Group AG: Shareholders approve creation of authorised capital and revision to Articles of Association for initial public offering (IPO) 19.06.2017 / 19:08 584325 19.06.2017 ...
Atrium European Real Estate Limited
issuer: Atrium European Real Estate Limited Seaton Place 11-15 UK-JE4 0QH St Helier Jersey / Channel Islands phone: +44 (0)20 7831 3113 FAX: mail: richard.sunderland@fticonsulting.com WWW: http://www.aere.com ISIN: JE00B3DCF752 indexes: stockmarkets: Wien, Luxembourg Stock Exchange language: English ...
Caisse de dépôt et placement du Québec
Montréal and Shannon, Ireland (ots/PRNewswire) - - CDPQ to provide strategic capital over four years to create an aircraft leasing and financing platform alongside world-class operator GECAS - Platform will provide GECAS with increased flexibility to support future growth - Investment marks new milestone in the ...
EQS Group-Ad-hoc: Conzzeta / Key word(s): Profit Warning/Half Year Results Conzzeta: Strong business trend in 1HY 2017 19-Jun-2017 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 583607 19-Jun-2017 CET/CEST ...
Jaguar Land Rover Deutschland GmbH
Whitley, England (ots/PRNewswire) - - Jaguar Land Rover use new Gorillaz mixed reality app as innovative recruitment tool - App has a code-breaking challenge to test future engineering talent - Successful game players will be fast-tracked through Jaguar Land Rover's recruitment process - Global initiative aims to recruit more than 1,000 electronic and software ...
EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Offer AEVIS VICTORIA SA: Swiss Medical Network SA relève son offre d'acquisition à tous les actionnaires de la Holding du Tilleul Biel/Bienne SA suite à l'offre concurrente d'Hirslanden. 18-Jun-2017 / 15:04 CET/CEST Release of an ad hoc announcement pursuant to ...
Paris (ots/PRNewswire) - To discover the full release click here : http://mma.prnewswire.com/media/524398/Clarendelle.pdf The Clarendelle family of wines is growing, while maintaining its promise of a unique expertise in fine winemaking and blending, overseen by the Haut-Brion team of oenologists. (Logo: http://mma.prnewswire.com/media/524397/Clarendelle_Logo.jpg ) 2 ...
issuer: Lenzing AG A-A-4860 Lenzing phone: +43 7672-701-0 FAX: +43 7672-96301 mail: office@lenzing.com WWW: http://www.lenzing.com ISIN: AT0000644505 indexes: WBI, ATX stockmarkets: Wien language: English ...
Ottawa, Ontario (ots/PRNewswire) - Pythian (http://www.pythian.com/), a global IT services company that helps businesses adopt technologies to better compete, announced today that Creative Media Works, operating as BBM Messenger, has selected Pythian to help them move their mission-critical IT infrastructure for Android, iOS and Windows consumer BBM from BlackBerry ...
Zurich (ots) - Zürcher Kantonalbank issues 2.125% Additional Tier 1 bond with a notional amount of CHF 750 million as of 30 June 2017. Zürcher Kantonalbank has issued today a new Additional Tier 1 (AT1) bond with contingent write-down with a notional amount of CHF 750 million and a coupon of 2.125%, meeting a strong investor demand. The new AT1 bond ...
Lausanne (ots) - A total of 96 patients randomized in France and Switzerland. Results expected in Q1 2019. Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the completion of enrollment in dose finding and ...
Paris (ots/PRNewswire) - From 15th to 17th June 2017, along with other L'Oréal brands, La Roche-Posay will be present among emerging start-ups and global businesses that celebrate the second edition of VivaTech, the world's largest organization for tech-lovers, innovators, entrepreneurs and pioneers of the future. During these days, the brand will highlight the most ...
Ballerup, Denmark (ots/PRNewswire) - LEO Pharma today announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an investigational human monoclonal antibody that specifically targets the cytokine IL-13[1], which plays an important role in the development of moderate-to-severe atopic dermatitis[2]. Tralokinumab is not ...
DGAP-News: LION E-Mobility AG / Key word(s): Strategic Company Decision/Expansion LION E-Mobility AG: Starts to expand its activities to China, the Worlds' second largest EV Market 14.06.2017 / 18:29 The issuer is solely responsible for the content of this announcement. 583153 14.06.2017 ...
Ambleteuse, France (ots/PRNewswire) - When a dream becomes reality .... This Morning 8:03 Lift-off Landing 8:53 (French Time) 50 minutes of flight Jérôme Dauffy achieved his crazy challenge: to drive a flying car across the sea. (Logo: http://mma.prnewswire.com/media/523425/Magna_Presse_Logo.jpg ) (Photo: http://mma.prnewswire.com/media/523426/VAYLON_Flying_Car.jpg ) ...
Madrid (ots/PRNewswire) - Sirukumab Phase 3 Data Presented at the Annual European Congress of Rheumatology (EULAR) 2017 also Show Significant Improvement in Quality of Life Measures Janssen-Cilag International NV (Janssen) today announced long-term results from SIRROUND-T*, a pivotal Phase 3 study that showed ...